Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases

World Neurosurgery

Volumn 73, Issue 3, 2010, Pages 186-193

  Marko, Nicholas F ^a   Angelov, Lilyana ^a,b   Toms, Steven A ^d   Suh, John H ^b,c   Chao, Sam T ^b,c   Vogelbaum, Michael A ^a,b   Barnett, Gene H ^a,b   Weil, Robert J ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d GEISINGER MEDICAL CENTER   (United States)

Author keywords

Performance score; Radiation; Recursive partitioning analysis; Renal cell carcinoma; Stereotactic radiosurgery; Survival

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CARCINOMA; MALE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRESCRIPTION; RADIATION DOSE; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TUMOR VOLUME;

AGED; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; INCIDENTAL FINDINGS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77952102696     PISSN: 18788750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2009.02.011     Document Type: Article

References (35)

1. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., Werner-Wasik M., Demas W., Ryu J., Bahary J.P., Souhami L., Rotman M., Mehta M.P., and Curran Jr. W.J. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 9422 (2004) 1665-1672
2. Aoyama H., Shirato H., Tago M., Nakagawa K., Toyoda T., Hatano K., Kenjyo M., Oya N., Hirota S., Shioura H., Kunieda E., Inomata T., Hayakawa K., Katoh N., and Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295 21 (2006) 2483-2491
3. Aoyama H., Tago M., Kato N., Toyoda T., Kenjyo M., Hirota S., Shioura H., Inomata T., Kunieda E., Hayakawa K., Nakagawa K., Kobashi G., and Shirato H. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68 5 (2007) 1388-1395
4. Beitler J.J., Makara D., Silverman P., and Lederman G. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol 27 6 (2004) 646-648
5. Cannady S.B., Cavanaugh B.S., Lee S.Y., Bukowski R.M., Olencki T.E., Stevens G.J.H., Barnett G.H., and Suh J.H. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Rad Oncol Biol Phys 58 1 (2004) 253-258
6. Chang E.L., Selek U., Hassenbusch S.J., Maor M.H., Allen P.K., Mahajan A., Sawaya R., and Woo S.Y. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurg 56 5 (2005) 936-944
7. Clark P.E. Recent advances in targeted therapy for renal cell carcinoma. Curr Opin Urol 17 5 (2007) 331-336
8. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 29 (1989) 789-796
9. Decker D.A., Decker V.L., Herskovic A., and Cummings G.D. Brain metastases in patients with renal cell carcinoma: prognosis and treatment. J Clin Oncol 2 (1984) 169-173
10. Doh L.S., Amato R.J., Paulino A.C., and Teh B.S. Radiation therapy in the management of brain metastases from renal cell carcinoma. Oncology (2006) 3
11. Epstein B.E., Scott C.B., Sause W.T., Rotman M., Sneed P.K., Janjan N.A., Davis L.W., Selim H., Mohiuddin M., Wasserman T.H., et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28. Cancer 71 4 (1993) 1362-1367
12. Flickinger J.C. Radiosurgery of brain metastases from renal cell carcinoma: how can you improve on results like this?. Cancer J 6 6 (2000) 360-361
13. Goyal L.K., Suh J.H., Reddy C.A., and Barnett G.H. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma. Int J Rad Oncol Biol Phys 47 4 (2000) 1007-1012
14. Hernandex L., Zamorano L., Sloan A., Fontanesi J., Lo S., Levin K., Li Q., and Diaz F. Gamma knife radiosurgery for renal cell carcinoma brain metastases. J Neurosurg (Suppl 5) 97 (2002) 489-493
15. Hoshi S., Jokura H., Nakamura H., Shintaku I., Ohyama C., Satoh M., Saito S., Fukuzaki A., Orikasa S., and Yoshimoto T. Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients. Int J Urol 9 (2002) 618-625
16. Kondziolka D., Patel A., Lunsford L.D., Kassam A., and Flickinger J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45 (1999) 427-434
17. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics 1999. CA Cancer J Clin 49 (1999) 8-31
18. Li J., Bentzen S.M., Renschler M., and Mehta M.P. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 25 10 (2007) 1260-1266
19. Manon R., O'Neill A., Knisely J., Werner-Wasik M., Lazarus H.M., Wagner H., Gilbert M., and Metha M. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group Study (E 6397). J Clin Oncol 23 34 (2005) 8870-8876
20. Manon R., O'Neill A., Knisely J., Werner-Wasik M., Lazarus H.M., Wagner H., Gilbert M., Mehta M., and Eastern Cooperative Oncology Group. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol 23 34 (2005) 8870-8876
21. Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., Kunkler I., Caudrelier J.M., Eisenberg P.D., Meerwaldt J., Siemers R., Carrie C., Gaspar L.E., Curran W., Phan S.C., Miller R.A., and Renschler M.F. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22 1 (2004) 157-165
22. Mori Y., Kondziolka D., Flickinger J.C., Logan T., and Lunsford L.D. Stereotactic radiosurgery for brain metastasis for renal cell carcinoma. Cancer 83 2 (1998) 344-353
23. Muacevic A., Kreth F.W., Mack A., Tonn J.C., and Wowra B. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma. Minim Invas Neurosurg 47 (2004) 203-208
24. Noel G., Valery C.A., Boisserie G., Cornu P., Hasboun D., Simon J.M., Tep B., Ledu D., Delattre J.Y., Marsault C., Baillet F., and Mazeron J.J. LINAC radiosurgery for brain metastasis of renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations, 22 (2004) 25-31
25. O'Dea M.J., Zincke H., Utz D.C., and Bernatz P.E. The treatment of renal cell carcinoma with solitary metastasis. J Urol 120 (1978) 540-542
26. Patchell R.A., and Regine W.F. The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases. Technol Cancer Res Treat 2 (2003) 111-115
27. Patchell R.A., Tibbs P.A., Regine W.F., Dempsey R.J., Mohiuddin M., Kryscio R.J., Markesbery W.R., Foon K.A., and Young B. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280 (1998) 1485-1489
28. Petrovich Z., Yu C., Giannotta S.L., O'Day S., and Apuzzo M.L.J. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. J Neurosurg Suppl 5 (2002) 499-506
29. Salvati M., Scarpinati M., Orlando E.R., Celli P., and Gagliardi F.M. Single brain metastases from kidney tumors. Clinico-pathologic considerations on a series of 29 cases. Tumori 78 6 (1992) 392-394
30. Schoggl A., Kitz K., Ertl A., Dieckmann K., Saringer W., and Koos W.T. Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients. Acta Neurochir (Wein) 140 (1998) 549-555
31. Seaman E.K., Ross S., and Sawczuk I.S. High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma. J Neurooncol 23 3 (1995) 253-256
32. Sheehan J.P., Sun M.H., Kondziolka D., Flickinger J., and Lunsford D. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98 (2003) 342-349
33. Shuto T., Inomori S., Fujino H., and Nagano H. Gamma knife surgery for metastatic brain tumors from renal cell carcinoma. J Neurosurg 105 (2006) 555-560
34. Walsh P.C., Retik A.B., Vaughan E.D., Wein A.J., Kavoussi L.R., Novick A.C., and Partin A.W. Peters CA: Campbell's urology (2002), Elsevier
35. Wronski M., Arbit E., Russo P., and Galicich J.H. Surgical resection of brain metastases from renal cell carcinoma in 50 patients. Urology 47 (1996) 187-193